Ameriprise’s Glaukos GKOS Stock Holding History

Ameriprise’s Portfolio GKOS Stock Details GKOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,200	Closed	-$1.3M	–	4033
2025 Q1	$1.3M	Sell	13,200 -4,000	-23%	-$534K	﹤0.01%	3100
2024 Q4	$2.58M	Buy	+17,200	New	+$2.37M	﹤0.01%	2779

Other funds holding GKOS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ameriprise's GKOS Position: Q2 2026 in Review

Ameriprise reduced its Glaukos (GKOS) stake by 18% in Q2 2026, selling an estimated $37.4M and leaving 1,315,057 shares worth $184M. The position accounts for 0.04% of the portfolio, ranked #409.

Ameriprise first reported a position in GKOS in Q2 2015 and has held it in 45 quarters since. The position peaked at $290M in Q4 2024. 367 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

Ameriprise held 1,315,057 shares of Glaukos worth $184M as of Q2 2026.
Ameriprise sold 295,717 Glaukos shares in Q2 2026, an estimated $37.4M.
Glaukos made up 0.04% of Ameriprise's portfolio in Q2 2026, its #409 holding.
Ameriprise first reported a position in Glaukos in Q2 2015 and has held it in 45 quarters since.
Ameriprise's Glaukos position peaked at $290M in Q4 2024.
367 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.